Clinical Trials on Ductal Infiltrating Metastatic Breast Cancer in Belgium
Total 789 results
-
Jules Bordet InstituteCompletedMetastatic Colorectal Cancers | Metastatic Gastric Cancers | Metastatic Oesophageal Cancers | Metastatic Pancreatic Cancers | Metastatic Biliary Cancers | Metastatic Breast CancersBelgium
-
Brugmann University HospitalUnknown
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Stage IV Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer FemaleUnited States, Belgium, Bulgaria, Georgia, Netherlands, Moldova, Republic of, Ukraine
-
PharmaMarCompletedMetastatic Colorectal Cancer | Pancreatic Cancer | Metastatic Breast CancerSpain, Belgium
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Breast Cancer | Metastatic Triple Negative Breast CancerJapan, Belgium, France, Netherlands
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
ABSCINT NV/SANot yet recruiting
-
Jules Bordet InstituteUnknownBreast Cancer | Metastatic CancerBelgium
-
Stemline Therapeutics, Inc.CompletedMetastatic Breast CancerNetherlands, Belgium
-
Jules Bordet InstituteGlaxoSmithKline; Schering-PloughCompletedMetastatic Breast Cancer | Brain Metastases | HER2 PositiveBelgium
-
Modra PharmaceuticalsCompletedMetastatic Breast Cancer | Recurrent Breast CancerDenmark, Belgium, Spain
-
Oslo University HospitalBristol-Myers Squibb; Helse Stavanger HF; Sorlandet Hospital HF; Cliniques universitaires... and other collaboratorsCompletedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive TumorNorway, Belgium
-
Jules Bordet InstituteBreast International GroupCompletedMetastatic Breast CancerBelgium, Spain, Germany, United Kingdom
-
AstraZenecaCompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerBelgium, Canada, Austria, Australia
-
Universitaire Ziekenhuizen KU LeuvenPfizerCompletedMetastatic Breast CancerBelgium
-
AstraZenecaCompleted
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerBelgium, United States
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedMetastatic Breast CancerFrance, Austria, Belgium, Australia, Italy
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER-2 Positive Breast CancerBelgium, Netherlands, Australia, Italy, United States
-
Cancer Research AntwerpCompleted
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer (PYTHIA)Metastatic Breast CancerUnited Kingdom, Belgium, Italy
-
Eisai Inc.Approved for marketingMetastatic Breast CancerCanada, Belgium, France
-
Teva PharmaCompletedMetastatic Breast CancerBelgium
-
Amal TherapeuticsBoehringer IngelheimActive, not recruitingMetastatic Colorectal Cancer | Colorectal Cancer | Liver Metastasis Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer | MSSUnited States, Belgium, Switzerland, Germany
-
Cristal TherapeuticsCompletedCancer | Metastatic Cancer | Solid TumorsNetherlands, Belgium
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerSpain, Australia, Belgium, Turkey, Russian Federation
-
PfizerTerminatedBreast Cancer MetastaticUnited States, Spain, Belgium, Italy
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
SanofiCompletedBreast Cancer, MetastaticAustralia, Belgium, France, Italy, Netherlands, Spain
-
Heidelberg Pharma AGU.S. Army Medical Research and Development CommandCompletedMetastatic Breast CancerUnited States, Belgium, Brazil, Germany, Israel
-
Novartis PharmaceuticalsTerminatedMetastatic Cancer With Impaired Renal Function | Metastatic Cancer With Normal Renal FunctionBelgium
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticFrance, Germany, Spain, Austria, Belgium, Slovenia, Poland, Bulgaria, United Kingdom, Italy
-
Jules Bordet InstituteHoffmann-La RocheRecruitingHER2-negative Breast Cancer | ER+ Breast Cancer | Invasive Lobular Breast CarcinomaBelgium, France
-
Merus N.V.CompletedBreast Cancer MetastaticUnited States, France, Belgium, Spain, United Kingdom, Netherlands, Portugal
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerBelgium, Turkey, Canada, Poland, Romania, Hungary, France, Czechia
-
Xenothera SASRecruitingMetastatic Cancer | Advanced Solid TumorFrance, Belgium
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerBelgium, France, Netherlands, United States, Spain
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
AmgenCompletedCancer | Breast Cancer | Breast Neoplasms | Metastatic Cancer | Breast Tumors | Solid Tumors | Oncology | Tumors | Metastases | Locally Recurrent and Metastatic Breast CancerUnited States, Belgium, France
-
Allarity TherapeuticsRecruitingMetastatic Breast CancerFinland, Poland, Germany, United Kingdom, Belgium, Italy, Netherlands
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States
-
Breast International GroupJules Bordet Institute; Frontier Science & Technology Research Foundation,...RecruitingMetastatic Breast CancerBelgium, Spain, Portugal, United Kingdom, Italy, Germany, Iceland, Luxembourg, Sweden, Switzerland
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerUnited States, Spain, Belgium, France
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer | HER2+ Breast CancerBelgium, France, Spain, United States, United Kingdom, Italy
-
AstraZenecaDaiichi Sankyo Co., Ltd.; Daiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerBelgium, United States, Taiwan, Korea, Republic of, Brazil, Russian Federation, Canada, Australia, France, Mexico
-
The Belgian Society of Medical OncologyRecruiting
-
University Hospital, GhentCompletedMetastatic Urothelial CancerBelgium
-
University Hospital, AntwerpUniversitair Ziekenhuis Brussel; General Hospital Groeninge; AZ Nikolaas; Erasme... and other collaboratorsActive, not recruitingMetastatic Pancreatic Ductal AdenocarcinomaBelgium